OK SB 771
died on adjournmentAdvertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense. Effective date. Emergency.
Oklahoma · 2026 Regular Session · upper
Quick answers
Did OK SB 771 pass?
No. OK SB 771 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-02-04): Second Reading referred to Health and Human Services
What is OK SB 771 about?
OK SB 771 is a bill in the 2026 Regular Session titled “Advertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense. Effective date. Emergency.”.
Who sponsors OK SB 771?
Deevers is the primary sponsor of OK SB 771.
- Introduced
- 2025-02-03
- Latest action
- 2025-02-04 — Second Reading referred to Health and Human Services
- Bill type
- bill
- Last updated
- —
Sponsors
- Deeversprimary
Committees
Not provided by source.
Action timeline
2025-02-03
First Reading
introduction,reading-1
2025-02-03
Authored by Senator Deevers
2025-02-04
Second Reading referred to Health and Human Services
reading-2,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:30:20.811026Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=OK&identifier=SB 771. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.